Determinants of circulating sobule transferrin receptor level in chronic haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 17, Issue 6, 2002, Pages 1063-1069

  Tarng, Der Cherng ^a   Huang, Tung Po ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Haemodialysis; Recombinant human erythropoietin; Soluble transferrin receptor

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; FERRITIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; TRANSFERRIN RECEPTOR; ANTIANEMIC AGENT; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ANEMIA; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; BONE MARROW; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION FUNCTION; DOSE RESPONSE; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; GENDER; HEMATOCRIT; HEMODIALYSIS PATIENT; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; KIDNEY FUNCTION; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETICULOCYTE COUNT; BLOOD; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REGRESSION ANALYSIS; RENAL REPLACEMENT THERAPY;

BIOLOGICAL MARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EPOETIN ALFA; ERYTHROPOIESIS; FEMALE; HEMATINICS; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RECEPTORS, TRANSFERRIN; REGRESSION ANALYSIS; RENAL DIALYSIS;

EID: 0035990783     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Correction of the anemia of end-stage renal disease with recombinant erythropoietin. Results of phase I and II clinical trial
2. Erythropoietin hyporesponsiveness: From iron deficiency to iron overload
3. Detection of functional iron deficiency during erythropoietin treatment: A new approach
4. Serum transferrin receptor as a new index of erythropoiesis
5. Cellular iron metabolism
6. Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin
7. Markers of masked iron deficiency and effectiveness of Epo therapy in chronic renal failure
8. Serum transferrin receptor: A quantitative measure of tissue iron deficiency
9. Plasma transferrin receptor levels and indices of erythropoiesis and iron status in healthy term infants
10. Serum transferrin receptor levels in anaemic patients with rheumatoid arthritis
11. The importance of serum transferrin receptor level in the diagnosis of functional iron deficiency due to recombinant human erythropoietin treatment in hemodialysis patients
12. Correction of the anemia of chronic renal failure with erythropoietin: Pharmacokinetic studies in patients on haemodialysis and CAPD
13. Pharmacokinetics of recombinant human erythropoietin in dialysis patients after single and multiple subcutaneous administration
14. Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: The case for subcutaneous administration
15. Regulation of cellular iron metabolism by erythropoietin: Activity of iron-regulatory protein and upregulation of transferrin receptor expression in erythroid cells
16. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure
17. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. III. Iron support
18. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Target guideline 6: Assessing and optimizing iron stores
19. Factors determining the percentage of hypochromic red blood cells in hemodialysis patients
20. Serum transferrin receptor and transferrin-ferritin index identify healthy subjects with subclinical iron deficits